Diabetes Insipidus: all 120 studies
Page 1 of 2. Open to participants first (30), then studies with results posted, then the rest; newest registration first within each.
- Effects of Increased Water Intake on Hormonal Response, Hydration Status, and Physical Function in Low-drinking Older AdultsNot yet recruitingNCT07892742Not applicable
- Oromucosal Oxytocin and Vasopressin Modulation of Emotional Face AttentionRecruitingNCT07838493Not applicable
- Biological Profiles of Neuropeptides, Neurotrophins and miRNA in MigraineNot yet recruitingNCT07832032
- Effect of Adding Vasopressin on Cardiac Output, Blood Pressure, Diuresis, and Tissue Perfusion Indices in Patients With Septic ShockNot yet recruitingNCT07697144
- Copeptin Measurement After Mannitol and Hypertonic Saline for the Diagnosis of Polyuria-polydipsia SyndromeRecruitingNCT07569861Not applicable
- A Study in Adult Males With X-linked Congenital Nephrogenic Diabetes Insipidus to Test the Effects of NDI-5001 Given for Multiple Days and to Test How NDI-5001 is Tolerated and Taken up in the BodyRecruitingNCT07525960Phase 1
- Serum Copeptin as Biomarker for Diagnosis and Classification of Polyuric Primary Monosymptomatic Nocturnal EnuresisNot yet recruitingNCT07496541
- Tranexamic Acid vs Vasopressin in Placenta Previa TrialNot yet recruitingNCT07423156Phase 3
- Plasma Oxytocin Response to Oral Estrogens in Healthy Controls and AVP-DeficiencyRecruitingNCT07361263Not applicable
- Plasma Oxytocin Changes in Response to Music Modified by Sonic Augmentation TechnologyRecruitingNCT07276152Not applicable
- Endocan and Copeptin Serum Levels in Preterm Neonates With Respiratory Distress SyndromeRecruitingNCT07154134
- Weaning Approaches for Vasopressin in SepsisRecruitingNCT07067866Phase 3
- Protein Supplementation in Hyponatremia Due to the Syndrome of Inappropriate AntidiuresisRecruitingNCT06821802Not applicable
- Copeptin and Thirst: Possible Predictive Markers of Effectiveness of Bariatric Surgery?RecruitingNCT06806787
- Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy ControlsRecruitingNCT06789705Not applicable
- The Trend of Copeptin Levels and Its Clinical Value for Postoperative CDI in Pediatric Patients After NSI in ICURecruitingNCT06742060
- Early Versus Late Adjunctive Vasopressin in Septic ShockRecruitingNCT06709573Phase 4
- Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy ControlsRecruitingNCT06676774Phase 2
- Arginin-stimulated Copeptin in Polyuria-polydipsia Syndrome in ChildrenNot yet recruitingNCT06604975Not applicable
- Norepinephrine and Vasopressin for Rescue Versus Early Vasopressin for Vasopressor Dependent SepsisRecruitingNCT06464510Phase 3
- A Study of Lower Radiotherapy Dose to Treat Children With CNS GerminomaRecruitingNCT06368817Phase 2
- Efficacy of a Smart Water Bottle Intervention to Increase Fluid Consumption in College StudentsRecruitingNCT06259799Not applicable
- The Effect of Prehospital Combination of Epinephrine, Vasopressin, and Steroid in OHCARecruitingNCT06203847Not applicable
- National Registry of Rare Kidney DiseasesRecruitingNCT06065852
- Oxytocin Substitution Therapy in Patients With Central Diabetes InsipidusRecruitingNCT06036004Phase 2
- CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) TrialRecruitingNCT05958342Phase 2
- Effects of Ephedrine, Phenylephrine, Norepinephrine and Vasopressin on Contractility of Human Myometrium and Umbilical Vessels: An In-vitro StudyRecruitingNCT04053478Not applicable
- Vasopressin and Pain Perception in the BrainRecruitingNCT03446456Phase 1/2Results posted
- Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical StudyRecruitingNCT02841553
- Vasoactive Drugs in Intensive Care UnitRecruitingNCT02118467Phase 4
- I-Tracking Neurodegeneration in Early Wolfram SyndromeCompletedNCT03951298Results posted
- Rectal Misoprostol as a Hemostatic Agent During Abdominal MyomectomyCompletedNCT03064568Phase 4Results posted
- A Multicenter Trial to Investigate the Efficacy and Safety of Tolvaptan in Patients With Hyponatremia in SIADHCompletedNCT03048747Phase 3Results posted
- Tolvaptan For Worsening Outpatient Heart Failure: Role of Copeptin In Identifying RespondersCompletedNCT02476409Phase 4Results posted
- Shared Health Appointments and Reciprocal Enhanced SupportCompletedNCT02132676Results posted
- A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)CompletedNCT02009878Phase 1/2Results posted
- AVERT Shock: Arginine Vasopressin During the Early Resuscitation of Traumatic ShockCompletedNCT01611935Phase 2Results posted
- Pilot Study of Using Copeptin to Predict Response to TolvaptanCompletedNCT01346072Phase 4Results posted
- Study of Dopamine Versus Vasopressin for Treatment of Low Blood Pressure in Low Birth Weight InfantsCompletedNCT01318278Not applicableResults posted
- 1-deamino 8-d-arginine Vasopressin (DDAVP) in Percutaneous Ultrasound-guided Renal BiopsyCompletedNCT00748072Phase 4Results posted
- Pharmacologic Treatment of Congenital Nephrogenic Diabetes InsipidusCompletedNCT00478335Not applicableResults posted
- Copeptin Concentration Measured in Plasma Samples and Intradialytic Blood Pressure VariationActive, not recruitingNCT07438925
- The Effects of Oxytocin and Vasopressin on Delta-beta Cross-frequency CouplingCompletedNCT06605300Not applicable
- Mannitol-induced Release of Copeptin in Healthy Adults and Patients With Polyuria-Polydipsia Syndrome (MARS Study)CompletedNCT06542198Not applicable
- Vasopressin for Septic Shock Pragmatic TrialCompletedNCT06217562Phase 4
- Water and Coffee Intervention in HumansCompletedNCT06165185Not applicable
- Multimodal Vasopressor Strategy in Septic ShockCompletedNCT06155812Phase 2/3
- Plasma Copeptin in Response to Oral Urea in Healthy Adults and Patients With Polyuria-polydipsia SyndromeCompletedNCT05890690Not applicable
- Potential Benefits of the Somatic Psychoeducational InterventionCompletedNCT05766852Not applicable
- Electrophysiology of the Human Pituitary GlandTerminatedNCT05338125Not applicable
- Identification and Clinical Relevance of an Oxytocin Deficient State (Melatonin Study)CompletedNCT05319301Not applicable
- Decline in Renal Concentration Ability in Lithium Treated PatientsStatus unknownNCT05307042
- Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium AdministrationCompletedNCT05190744Phase 2
- AMIloride for the Treatment of Nephrogenic Diabetes Insipidus for Patients With Bipolar Disorder Treated With LithiumActive, not recruitingNCT05044611Phase 4
- Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)CompletedNCT04902235Phase 4
- Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)CompletedNCT04897802Phase 4
- Copeptin and Psychological Stress of Medic During COVID-19 PandemicCompletedNCT04757285
- Circulating Oxytocin Changes in Response to the Oxytocin System Stimulator MDMA in Patients With Diabetes Insipidus and Healthy ControlsCompletedNCT04648137Not applicable
- Copeptin After a Subcutaneous Stimulation With Glucagon in AdultsCompletedNCT04550520Not applicable
- Copeptin as a Biomarker for Central Diabetes Insipidus Development Following Pituitary SurgeryCompletedNCT04369703
- Endocrine Changes and Their Correction in Heart and Lung Transplant Recipients and DonorsStatus unknownNCT04351945
- Copeptin and the S-100b Protein in StrokeCompletedNCT03974464
- Serum Copeptin as a Predictor of the Risk of Hyponatremia After Transurethral ProstatectomyCompletedNCT03912766
- The Influence of Water and Salt Intake on Copeptin Levels During Moderate Alcohol ConsumptionCompletedNCT03883503Not applicable
- Copeptin After an Oral Stimulation With Macimorelin in Healthy VolunteersCompletedNCT03844217Not applicable
- Copeptin Serum Level in Liver Transplant RecipientsCompletedNCT03587623
- Use of Copeptin Measurement After Arginine Infusion for the Differential Diagnosis of Diabetes Insipidus - the CARGOx StudyCompletedNCT03572166Not applicable
- Evaluation of Copeptin Levels in Elective Cesarean Section With Different Anesthetic TechniqueCompletedNCT03536910Not applicable
- The Effect of Midazolam Premedication on Copeptine Concentration in BloodCompletedNCT03474939Phase 4
- Seoul National University Pituitary Disease Cohort StudyStatus unknownNCT03474601
- Hydration to Optimize MetabolismCompletedNCT03422848Not applicable
- Evaluation of Copeptin in Patients With Cirrhosis and AscitesCompletedNCT03318601Not applicable
- Copeptin- Relevance as a Perioperative Marker in Pediatric Cardiac SurgeryCompletedNCT03316508
- Prediction of Inflammatory Response and Hypotensive Syndrome After Cardiac Surgery by Preoperative Copeptin LevelCompletedNCT03288610
- Copeptin in Outcome Prediction of an Acute Psychotic EpisodeCompletedNCT03235908
- Proadrenomedullin and Copeptin in Patients With Septic ShockCompletedNCT03104933
- Prognostic Value of Copeptin for Infarct Size and Prognosis in Patients With ST-elevation Myocardial InfarctionStatus unknownNCT03074214
- Atorvastatin for the Treatment of Lithium-Induced Nephrogenic Diabetes InsipidusCompletedNCT02967653Phase 2
- Effects of GLP-1 Analogues on Fluid Intake in Patients With Primary Polydipsia (The GOLD-Study)CompletedNCT02770885Phase 2
- Perioperative Copeptin: Predictive Value and Risk Stratification in Patients Undergoing Major SurgeryCompletedNCT02687776
- Copeptin in Normal- to Hyperosmolar StatesCompletedNCT02647736Not applicable
- Regulation of Arginine-vasopressin (AVP)CompletedNCT02626832Not applicable
- Copeptin for Prediction of Treatment Response in Children With Monosymptomatic Nocturnal Enuresis (MEN).CompletedNCT02621736
- The Circadian Rhythm of CopeptinCompletedNCT02604875
- Effect of Statin Treatment on Urinary AQP2 (uAQP2/01)CompletedNCT02523001
- Copeptin Registry (proCORE) Biomarkers in Cardiology (BIC)-19CompletedNCT02490969
- Metformin and Congenital Nephrogenic Diabetes InsipidusTerminatedNCT02460354Phase 1
- Tracking Neurodegeneration in Early Wolfram SyndromeCompletedNCT02455414
- Copeptin Testing During Pre-hospital Care in the Treatment of Chest Pain Suggestive of Acute Coronary SyndromeCompletedNCT02116426
- Copeptin as a Stress Marker During a Written ExaminationCompletedNCT02051647
- Fetal Copeptin After Oxytocin Challenge TestCompletedNCT01962701
- Diagnostic Utility of Copeptin in Addition to High-sensitivity Cardiac Troponin for the Early Diagnosis of NSTE-ACSStatus unknownNCT01962506
- Use of Copeptin in Diabetes InsipidusCompletedNCT01940614
- Copeptin After Arginine Infusion in Polyuria-Polydipsia SyndromeCompletedNCT01879137
- Copeptin During a Standardized Psychological Stress TestCompletedNCT01866137
- Biomarkers In Seizure To Predict Recurrence and Severe OutcomesCompletedNCT01774500
- Copeptin Changes After Food IntakeCompletedNCT01772914
- Acute Heart Failure Patients With High Copeptin Treated With Tolvaptan Targets Increased AVP Activation for Treatment (ACTIVATE)WithdrawnNCT01733134Phase 3
- Copeptin in Aortic Valve ReplacementCompletedNCT01648647
- Effect of the Biomarker Copeptin in Managing Patients With Suspected Acute Coronary Syndrome (ACS)CompletedNCT01498731Not applicable